Development of New Technologies Needed for Studying the Human Microbiome (R21)

The summary for the Development of New Technologies Needed for Studying the Human Microbiome (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Development of New Technologies Needed for Studying the Human Microbiome (R21): Purpose. The purpose of this FOA is to solicit applications to develop new and improved technologies for obtaining samples of individual microbial isolates or strains, from the human microbiota, suitable for complete genomic sequence analysis. The goal is to expand the number of reference microbial genome sequences, which in turn will aid in the analysis of the complex microbial populations resident in and on the human body. Mechanism of Support. This FOA will utilize the NIH Exploratory/Developmental Research Grant (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, RFA-RM-09-008 that solicits applications under the R01 mechanism. Funds Available and Anticipated Number of Awards. $2 million is available in FY10 for this FOA and the parallel R01 FOA in combination. It is anticipated that 2-4 R01 grants and 2-6 R21 grants will be awarded. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Federal Grant Title: Development of New Technologies Needed for Studying the Human Microbiome (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-RM-09-009
Type of Funding: Grant
CFDA Numbers: 93.310
CFDA Descriptions: Trans-NIH Research Support
Current Application Deadline: Sep 14, 2009
Original Application Deadline: Sep 14, 2009
Posted Date: Jul 16, 2009
Creation Date: Jul 16, 2009
Archive Date: Oct 15, 2009
Total Program Funding: $2,000,000
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) .
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
Using Metabolomics to Investigate Biological Pathways and Networks (R01)
Assay Development for High Throughput Molecular Screening (R21)
Membrane Protein Production and Structure Determination (R01)
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com